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Abstract 
Here we show that the phosphorylation of histone acetyltransferase Tip60, a target of human 
immunodeficiency virus, type 1-encoded transactivator Tat, plays a crucial role in the control 
of its catalytic activity. Baculovirus-based expression and purification of Tip60 combined with 
mass spectrometry allowed the identification of serines 86 and 90 as two major sites of 
phosphorylation in vivo. The phosphorylation of Tip60 was found to modulate its histone 
acetyltransferase activity. One of the identified phosphorylated serines, Ser-90, was within a 
consensus cyclin B/Cdc2 site. Ser-90 was specifically phosphorylated in vitro by the cyclin 
B/Cdc2 complex. Accordingly, the phosphorylation of Tip60 was enhanced after drug-induced 
arrest of cells in G2/M. This G2/M-dependent phosphorylation of Tip60 was abolished by 
treating cells with a specific inhibitor of the cyclin-dependent kinase, roscovitin. All together, 
these results strongly suggest a G2/M-dependent control of Tip60 activity. 
 
Introduction 
Tip60 was first identified as a partner of human immunodeficiency virus, type 1-encoded 
transactivator protein Tat (1). Later, investigations clearly showed it to be a specific member 
of the MYST family of nuclear histone acetyltransferases (HATs)1 (2). Although the targeting 
of Tip60 by Tat was found to interfere with its HAT activity and to disturb the expression of 
at least one cellular gene (3), the function of Tip60 remained elusive until recently. Indeed, the 
identification of proteins associated with ectopically expressed Tip60 showed the presence of 
associated ATPase and DNA helicase activities. Functional tests showed that Tip60 and 
associated proteins may play an essential role in DNA repair and apoptosis (4). Moreover, 
considering other recent reports, it appears that Tip60 is involved in a wide variety of cellular 
functions. For instance, Tip60 was found to interact with the androgen receptor and to 
enhance its transactivation in a ligand-dependent manner (5). Moreover, androgen receptor 
was found to be a substrate for Tip60 (6). Other steroid receptors such as estrogen and 
progesterone receptors have also shown an enhanced activity in the presence of Tip60 and 
their ligands (5). Tip60 has also been involved in the NF B response system, because it was 
found to interact directly with BCL-3, a member of I B family. BCL-3 is thought to serve as 
an adaptor-bridging Tip60 to the NF B p50/p52 and to participate in the gene activation 
function of this transcription factor (7). Moreover, it has recently been shown that interleukin-
1  induces the activation of a specific group of NF B-responsive genes including KAl1 in 
relation to the selective recruitment of Tip60 to the promoter of this gene (8). Other studies (9) 
showed that Tip60 can interact with interleukin-9 (IL-9) receptor, suggesting its possible role 
in IL-9 signaling. Tip60 was also found to interact directly with cAMP response element-
binding protein (CREB) and interfere with its activity, implicating this HAT in the cAMP-
dependent signaling process (10). Moreover, Tip60 was also shown to interact with one of the 
endothelin receptors, ETA (11). All of these examples point to an important involvement of 
Tip60 in various receptor-mediated signaling processes. In agreement with this hypothesis, it 
has recently been shown that Tip60 is an essential component linking the proteolytic cleavage 
of Amyloid-  precursor protein to transcriptional activation (8, 12).  
The important function of Tip60 in cell signaling is probably the reason for its targeting by 
the HIV-1-encoded transactivator Tat. Indeed, it appears that Tat uses Tip60 to control 
cellular events for the benefit of the virus (13). Here we evidenced a new property of Tip60. 
First, Tip60 has been shown to be phosphorylated in vivo, and second, two major sites of 
Tip60 phosphorylation have been discovered. The sequence of one of these sites 
encompassing serine 90 perfectly matches a Cdc2 phosphorylation site. We showed that cyclin 
B/Cdc2 complex can specifically phosphorylate Ser-90 in vitro and in vivo and that the 
phosphorylation of Tip60 was enhanced in G2/M phase of the cell cycle. This specific G2/M 
phosphorylation of Tip60 was inhibited when cells were treated with a specific inhibitor of 
cyclin-dependent kinase, roscovitin. Our data clearly show that the phosphorylation of Tip60 
controls its HAT activity and strongly suggest a role for Tip60 HAT activity in the control of 
G2/M-related events.  
Materials and Methods 
Production and Purification of Proteins in Baculovirus-- Wild type or mutant Tip60 cDNA 
were cloned into pBacPAK9 transfer vector (Clontech) in-frame with a histidine tag at the C 
terminus or at the N terminus of the coding sequence. Viral particles were generated using the 
BacPAK baculovirus expression system (Clontech) and Sf21 insect cells. 2-3 days after 
infection, Tip60 proteins were purified from Sf21 cells by nickel affinity column (NiTA-
agarose, Qiagen), eluted with 250 mM imidazole, and finally dialyzed against 20 mM Tris, pH 
7.5, 10% glycerol, and 1 mM dithiothreitol. The purified proteins were kept at 20 °C and 
used in phosphatase treatment experiment, mass spectrometry analysis, and HAT assay (see 
below).  
Plasmids-- The plasmid pcDNA-HA-Tip60 has been described previously (14). The Tip60-(1-
211) mutant was generated by PCR and cloned in-frame with the HA tag in the pcDNA-HA 
vector. The point mutations were generated by PCR, and the incorporation of all of the 
mutations was confirmed by DNA sequencing. In the Gly-380 mutant, glycine 380 was 
replaced by an alanine. In the Ser-86, Ser-90, and Ser-86/Ser-90 mutants, the serines were 
replaced by alanines. In the Leu-254/Leu-257 mutant, the two indicated leucines were 
replaced by alanines.  
Phosphatase Treatment-- Five hundred nanograms of His-Tip60 proteins produced in 
baculovirus were incubated with 10 units of calf intestine phosphatase (CIP) (New England 
BioLabs) in the presence or absence of phosphatase inhibitor (5 mM NaF) for 30 min at 37 °C 
(or 1 h on ice when the dephosphorylation was followed by a HAT assay). Tip60 was then 
removed by incubation of the reaction mixture with NiTA-agarose beads and eluted with 
Laemmli sample buffer and subsequently analyzed by SDS-PAGE and Western blotting. 
Phosphatase treatment of endogenous Tip60 was performed as follows. HeLa cell nuclei 
isolated from 107 cells were incubated with 50,000 units of CIP for 30 min at 37 °C. Nuclei 
were washed three times in the lysis buffer (15 mM NaCl, 60 mM KCl, 12% sucrose, 2 mM 
EDTA, 0.5 mM EGTA, 0.65 mM spermidine, 1 mM dithiothreitol, 0.5 mM 
phenylmethylsulfonyl fluoride, 0.5% Triton X-100) and directly lysed in protein loading 
buffer. Tip60 was detected using an anti-Tip60 antibody described by Legube et. al. (14).  
Histone Acetyltransferase Assays-- HAT assays were performed using 4 µg of free core 
histones or 5 µg of oligonucleosomes, wild type, or mutant Tip60 proteins (100-200 ng) and 
0.15 µCi of [14C]acetyl-CoA (65 mCi/mmol) (ICN) in HAT buffer (25 mM Tris, pH 8.0, 10% 
glycerol, 100 mM NaCl, 1 mM dithiothreitol, 0.2 mM EDTA, 0.2 mM phenylmethylsulfonyl 
fluoride, 5 mM sodium butyrate) for 30 min at 30 °C. 50% of the reactions was loaded on a 
18% SDS-polyacrylamide gel followed by Coomassie Blue staining to ensure equivalent 
loading of histones in each lane, and fluorography was performed after incubation of the gel in 
the Amplify solution (Amersham Biosciences). In some assays, the HAT activity was 
analyzed with Tip60 immobilized on NiTA-agarose beads after alkaline phosphatase 
treatment.  
MALDI-MS Analysis-- Mass spectra of the tryptic digests were acquired on a Biflex (Bruker-
Franzen Analytik, Bremen, Germany) MALDI-TOF mass spectrometer equipped with a 
gridless delayed extraction. The instrument was operated in linear mode. 0.5 µl of the digest 
solution (in 25 mM NH4HCO3) was deposited directly onto the sample probe on a dry thin 
layer of matrix made of -cyano-4-hydroxy-trans-cinnamic acid mixed with nitrocellulose 
(mixture (4:3, v/v) of a saturated solution of -cyano-4-hydroxy-trans-cinnamic acid in 
acetone and a solution consisting of 10 mg of nitrocellulose dissolved in 1 ml of isopropyl 
alcohol/acetone (1:1, v/v)). The deposits were washed with 5 µl of 0.1% trifluoroacetic acid 
before the analysis. A mass list of peptides was obtained for each protein digest.  
Peptide Dephosphorylation-- Phosphorylated tryptic peptides were identified on the peptide 
mass fingerprint by a 80-Da (or multiples of 80 Da) mass shifts after the dephosphorylation 
step. The dephosphorylation reaction was done by treating the tryptic peptide mixture with 
bovine alkaline phosphatase in which the peptide digest (5 µl) was mixed with 5 µl of calf 
intestinal alkaline phosphatase immobilized on agarose beads (P0762, Sigma) in 25 mM 
NH4HCO3 buffer. After 30 min (37 °C), the peptide digest was directly deposited on the 
MALDI sample probe for analysis.  
Phosphopeptide Microcropurification-- Phosphopeptides were purified from the crude tryptic 
digest using immobilized metal ion affinity chromatography essentially as previously 
described (15). The tryptic digest (2 µl in 10 mM NH4HCO3, 5% acetic acid, 30% acetonitrile) 
was loaded on a ZipTipMC (ZT0MCS, Millipore,) that had been previously equilibrated 
following the recommendations of the manufacturer. The ZipTipMC column was then washed 
with 0.1% acetic acid followed by 0.1% acetic acid, 30% acetonitrile, and 0.1% acetic acid 
and finally eluted in 2% ammonium hydroxide (2 µl). Eluted peptides were then mixed with 
50 mM NH4HCO3 (v/v) and analyzed by MALDI-MS.  
Nanoelectrospray-MS/MS Analysis-- The digest solution was dried in a vacuum centrifuge 
and desalted with ZipTip C18 (Millipore, Bedford, MA) before the nanospray MS/MS 
analysis. A Q-TOF instrument (Micromass, Manchester, United Kingdom) was used with a Z-
spray ion-source working in the nanospray mode. Approximately 3-5 µl of the desalted 
sample was introduced into a needle (medium sample needle, PROTANA Inc. Odense, 
Denmark) to run MS and MS/MS experiments. The capillary voltage was set to an average 
voltage of 1000 V, and the sample cone was set to 50 V. Glufibrinopeptide was used to 
calibrate the instrument in the MS/MS mode. MS/MS spectra were transformed using 
MaxEnt3 (MassLynx), and amino acid sequences were analyzed using PepSeq (BioLynx).  
Kinase Assays-- Wild type or mutant Tip60 peptides (mutant Ser-90 and mutant Ser-86/Ser-
90) encompassing serines at positions 86 and 90 were synthesized, purified (Sigma), and 
reconstituted in distilled water at 5 mM. For the phosphorylation assays, 15 nmol of wild type 
or mutant peptides at a final concentration of 500 µM were incubated in Cdc2 kinase buffer 
supplemented with 100 µM cold ATP, 100 µM sodium vanadate, 10 µCi of [ -32P]ATP 
(3000 Ci/mmol, ICN), and 5 units of Cdc2 kinase/cyclin B (New England BioLabs) for 
30 min at 30 °C (final volume of 30 µl). In control reactions, the kinase or the peptide was 
omitted. Two volumes of 10% trichloroacetic acid and 20 µg of carrier bovine serum albumin 
were added at the end of the reaction, and the samples were spotted on P81 cellulose 
phosphate paper. Filters were then washed in 0.5% phosphoric acid (4 times, 10 min), rinsed 
in acetone, and finally used to measure 32P incorporation in a scintillation counter.  
Cell Culture, Transfection, Drug Treatments, and Western Blot-- HeLa cells were grown as 
described previously (14) and transfected using Exgen (Euromedex) or FuGENE 6 (Roche 
Molecular Biochemicals) as indicated by the suppliers. 24-48 h later, cells extracts were 
prepared by lysing cells directly in Laemmli sample buffer and sonicated. Stably Tip60 
expressing HeLa cells (a gift of Dr. V. Ogrysko) were grown in Dulbecco's modified Eagle's 
medium supplemented with fetal calf serum (10%) and antibiotics.  
Results 
Phosphorylation of Tip60 in Vivo-- To investigate the biochemical property of Tip60, we have 
expressed a histidine-tagged human Tip60 in insect cells using a baculovirus-based expression 
system. The recombinant protein was found to be an active HAT on purified histones as well 
as on nucleosomes (Fig. 1A). Interestingly, whereas Tip60 efficiently acetylated free histone 
H4 and H3, in nucleosomes, it essentially acetylated histone H4. However, the acetylation of 
nucleomosal H4 was much less efficient than that of free histones. Indeed, the gel containing 
nucleosomal histones had to be exposed for a longer period of time to obtain a comparable 
signal for the acetylation of free and nucleosomal H4. We have also noticed that the purified 
recombinant Tip60 migrated as a doublet on a 8% SDS-PAGE, and the treatment with the 
protein calf intestinal alkaline phosphatase prior to electrophoresis caused a shift of Tip60 to a 
faster migrating band (data not shown). This observation showed that protein phosphorylation 
was responsible for the observed shift in the electrophoretic mobility of Tip60. To determine 
the region of Tip60 concerned by phosphorylation, two fragments of Tip60 were expressed in 
insect cells, purified, and analyzed on a 15% SDS-PAGE, one containing the N-terminal 
chromodomain of Tip60 encompassing the first 211 amino acids and the other corresponding 
to the rest of the protein (Fig. 1B, schemes). Fig. 1B shows that the N-terminal fragment 
migrated as a doublet and that the CIP treatment caused a shift of the majority of the protein 
into a single fast migrating band (compare lane 1 with 2). The 212-513 region of Tip60 
migrated as a single band, and the CIP treatment did not affect its electrophoretic mobility 
(Fig 1B, lanes 3 and 4).  
Two Major Sites of Tip60 Phosphorylation in Vivo-- Data presented above showed that the 
major sites of Tip60 phosphorylation are located in the first 211 amino acids of the protein. To 
determine precisely the sites of Tip60 phosphorylation, we chose a mass spectrometry-based 
approach. First, the mass spectra of the tryptic fragments of the 1-211 region of Tip60 were 
compared with that of the tryptic fragments of the CIP-treated protein. The MALDI-TOF 
analysis showed that peptide-(81-93) bears two phosphate groups. The Q-TOF sequencing of 
peptide-(81-93) from phosphorylated and CIP-treated proteins confirmed the above 
conclusion and showed that serines 86 and 90 are phosphorylated. Finally, tryptic fragments of 
Tip60-(1-211) were loaded on a ZipTip-MC column capable of retaining phospho-peptides, 
and the MALDI-TOF analysis of these peptides confirmed again the presence of two 
phosphate groups on peptide-(81-93). This analysis also showed the possible presence of 
phosphate groups on 190-211 and 204-211 tryptic fragments (data not shown). To evaluate the 
respective participation of serines 86 and 90 in Tip60 phosphorylation, we mutated either 
serine 86 or serine 90 or both to alanine and monitored their migration on 8% SDS-PAGE 
after an ectopic expression in HeLa cells. As controls, we also expressed either a Tip60 
mutant in which glycine 380 was replaced by an alanine or Tip60 Leu-254/Leu-257 mutant in 
which the two indicated leucines potentially involved in a nuclear export signal were also 
changed to alanines. Fig. 2B shows that only mutations affecting serines 86 and 90 affect the 
mobility of Tip60, which strongly suggests that these sites are majors sites of Tip60 
phosphorylation in mammalian cells. This hypothesis was further confirmed by showing that 
CIP-treated Tip60-(1-211) fragment expressed in HeLa cells migrated at the same position as 
a Tip60-(1-211) fragment containing the Ser-86/Ser-90 mutation (Fig. 2C). All of these results 
showed that Tip60 can be phosphorylated both in insect and mammalian cells, and serines 
86 and 90 represent two major sites of phosphorylation in vivo. Finally, we showed that 
endogenous Tip60 detected in HeLa cell nuclear extracts migrated as a doublet and that the 
CIP treatment of the nuclei before the extract preparation led to the migration of Tip60 as a 
single band (Fig. 2D).  
 
Phosphorylation of Tip60 Modulates Its HAT Activity-- To evaluate the role of 
phosphorylation in the activity of Tip60, the HAT activity of purified phosphorylated Tip60 
was compared with that of the CIP-treated protein. Fig. 3A shows that the pretreatment of 
Tip60 with increasing amounts of CIP considerably reduced the HAT activity of the protein 
(compare lanes 2 and 3 with 1). In the same experiment when CIP was added in the presence 
of its inhibitor NaF (Fig. 3A, lanes 4-6) or heat-inactivated prior to its addition (Fig. 3B, lane 
9), no detectable modification of Tip60 HAT activity was observed compared with the 
control. These experiments show that the inhibition of Tip60 HAT activity is not because of 
the presence of CIP itself in the reaction medium but because of its ability to dephosphorylate 
Tip60. Moreover, the activity of the CIP-treated Tip60 was comparable with that of a mutated 
Tip60, Tip60Gly-380, containing a mutation severely affecting its HAT activity (Fig. 3B, lane 
11). In this mutant, a glycine critical for acetyl-CoA binding in all MYST members of HATs 
was replaced by an alanine. This mutation had been previously shown to inactivate the 
Drosophila Tip60 homologue MOF (16) and was also one of the two mutations introduced by 
Ikura et al. (4) to inactivate Tip60. The above experiment clearly showed that 
dephosphorylated Tip60 has a poor catalytic activity. To show the specific involvement of the 
serines 86 and 90 in the control of the HAT activity of Tip60, baculovirus-based expression 
was used to express and purify a mutated form of Tip60 (Tip60Ser-86/Ser-90) in which these two 
serines were replaced by alanines. A HAT assay was set up to compare the HAT activity of 
the wild type, phosphorylated Tip60 with that of Tip60Ser-86/Ser-90. Fig. 3C shows that, as in 
mammalian cells, the double mutant Tip60 migrated faster than the wild type protein (upper 
panel). Moreover, this experiment also showed that Tip60Ser-86/Ser-90 was not as efficient as 
wild-type Tip60 at acetylating histones.  
 
Kinases Involved in the Phosphorylation of Tip60-- The data presented thus far showed the 
critical role of Tip60 phosphorylation in the control of its catalytic activity. Therefore, it 
appeared very important to identify the kinases involved to better understand the functional 
significance of this regulation of Tip60 activity by its phosphorylation. The analysis of the 
sequence encompassing Ser-86 and Ser-90 showed that Ser-90 corresponded to a potential 
p34 Cdc2 phosphorylation site XSPX(R/K) (17). To test the ability of cyclin B/Cdc2 to 
phosphorylate Ser-90, we have synthesized three peptides encompassing the amino acid 82-96 
region of Tip60. One peptide corresponded to the wild type sequence, and the two others 
contained serine replacement (Ser to Ala) of either Ser-90 or both Ser-86 and Ser-90 (Fig. 
4A). The peptides were incubated with purified cyclin B/Cdc2 complex in the presence of 32P-
labeled ATP, and peptide phosphorylation was monitored. Fig. 4B shows that only the wild 
type peptide was phosphorylated by the purified cyclin B/Cdc2 complex. The phosphorylation 
of a peptide containing the "Ser-90 to Ala" mutation was comparable with that of a peptide 
containing replacements of both serines, Ser-86 and Ser-90, to alanines or that of the wild type 
peptide incubated with [32P]ATP in the absence of the enzyme. This experiment shows that 
cyclin B/Cdc2 specifically phosphorylates Ser-90 of Tip60. To show the participation of 
cyclin-dependent kinases (CDKs) in the phosphorylation of Tip60, HeLa cells were treated 
with nocodazole, inducing an arrest at G2/M phase of the cell cycle because of its ability to 
depolymerize microtubules. Nocodazole-treated cells were lysed, and Tip60 was detected 
using an anti-Tip60 antibody (14) when ~90% of cells were in the G2/M phase of the cell 
cycle (data not shown). Fig. 5A shows that, as expected, in cycling cells, Tip60 appeared as a 
doublet. Interestingly, after the treatment of cells with nocodazole, almost only the 
phosphorylated form of Tip60 was visible. However, in our hands for unknown reasons, the 
endogenous Tip60 could not be detected with a reasonable sensitivity in a reproducible 
manner. Therefore, to better investigate the involvement of the CDKs in the phosphorylation 
of Tip60, we used a characterized HeLa cell line stably expressing HA-tagged Tip60 (4) to 
evaluate Tip60 phosphorylation in response to specific drugs. In cycling HeLa cells, the HA-
Tip60 appeared also as a doublet. After the treatment of cells with nocodazole, the HA-Tip60 
behaved like the endogenous protein because the amount of the phosphorylated form of the 
protein increased (Fig. 5B, lane 3). This nocodazole-induced accumulation of phosphorylated 
HA-Tip60 was severely reduced when the nocodazole-treated cells were treated with 
roscovitin, a specific inhibitor of CDKs (18), for 7 h before the cell harvest (Fig. 5B, lane 4). 
All together, these data show the participation of CDKs in the phosphorylation of Tip60 and 
strongly suggest a role for Tip60 in the control of cell cycle-related events.  
 
Discussion 
The MYST family of histone acetyltransferases are evolutionary conserved enzymes from 
yeast to humans. The specific function of several members of this family is now emerging in 
different species (19). For instance, in yeast, two HATs of the MYST family, SAS2 and 
SAS3, play a role in silencing. The HAT activity of SAS3 has been shown in vitro (20), and 
moreover, it has been found within the NuA3 complex, which specifically acetylates histone 
H3 in nucleosomes (21). The third member of MYST HATs in yeast, Esa1, appears to be 
responsible for cell cycle progression (22). This HAT is also present in a complex known as 
NuA4 (23) and is required for DNA double-stranded break repair (24). In Drosophila, MOF, a 
MYST HAT, has been clearly shown to be involved in the male X chromosome 
hyperactivation by specifically acetylating histone H4 lysine 16 (16). Interestingly, as Tip60, 
MOF has a canonic chromodomain, which possesses the ability to bind to RNA in vitro and to 
the X chromosome-associated RNA in vivo (25). The role of other vertebrate MYST 
members, HBO1, MORF, and MOZ, has not yet been defined (19). Therefore, it appears that 
the HATs of the MYST family are involved in the control of a variety of critical cellular 
events. This conclusion implies that the activity and the expression of these enzymes should 
be tightly regulated. In the literature, there is almost no hint regarding this issue. Our data 
provide the first indication of the regulated expression and activity of a member of the MYST 
acetyltransferases, Tip60. Indeed, we have previously shown that the cellular concentration of 
Tip60 is controlled by Mdm2-mediated ubiquitination and proteasome-dependent degradation 
of the protein (14). Here we show that the phosphorylation of Tip60 is a controlled 
phenomenon and modulates the activity of the protein. Tip60 is not the only HAT whose 
activity is controlled by phosphorylation. Indeed, it has been shown that the transcription 
factor ATF-2 possesses an intrinsic HAT activity and that its phosphorylation considerably 
stimulates its HAT activity (26). Another example is CREB-binding protein, which is 
phosphorylated at the G1/S boundary, and this phosphorylation was also shown to stimulate its 
HAT activity (27). This phosphorylation-dependent control of CREB-binding protein activity 
allows this HAT to be responsive to distinct signaling pathways. Indeed, kinases as different 
as p44 MAPK/ERK1 (28), cell cycle-dependent kinases such as cyclin E/Cdk2 (27), as well as 
MEKK1 (29) are capable of phosphorylating and, hence, activating the CREB-binding protein 
catalytic activity. In the case of Tip60, Ser-90 is located within a canonic cyclin B/Cdc2 site 
and the enzyme was found here to specifically phosphorylate this specific serine. 
Interestingly, Ser-90 is highly conserved among Tip60 homologues in different species (data 
not shown), suggesting that this mode of regulation is also conserved during evolution. 
Furthermore, our data provide a new basis to reconsider the many functions of Tip60. Indeed, 
Tip60 appears as an important intermediate in several unrelated receptor-mediated signaling 
processes (5, 6, 8, 9, 11). Therefore, our data suggest that an additional control level, that of 
Tip60 phosphorylation, needs to be coordinated with signals induced by steroids (5, 6), IL-1  
(8), IL-9 (9), or endothelin (11). Besides, the HAT activity of Tip60 has been shown to be 
essential in the cellular response to DNA damage (4). Therefore, the phosphorylation of Tip60 
regulating its HAT activity could well play an important role in this process and somehow link 
Tip60 function to the replication checkpoint. Finally, the HAT activity of Tip60 was found to 
mediate gene activation following the cleavage of amyloid-  precursor (12). These data 
should also be reconsidered in the light of a linkage between Tip60 catalytic activity and its 
phosphorylation.  
In summary, this work has allowed to establish a link between CDKs and the activity of 
Tip60. However, other kinases may also phosphorylate Tip60, establishing a specific linkage 
between Tip60 activity and one or several of the signaling pathways discussed above.  
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Fig.  1.     The  enzymatically  active  Tip60  expressed  in  insect  cells  is  phosphorylated.  Baculovirus‐
based expression system was used  to produce His‐tagged human Tip60  (scheme)  in  insect cells. A, 
the purified enzyme  is capable of efficiently acetylating  free histones  (left panel) and nucleosomal 
histone H4 (right panel). B, the two indicated His‐tagged fragments of Tip60 (scheme) were produced 
in insect cells, treated or not with CIP (+ and  , respectively) and analyzed on 15% SDS‐PAGE stained 
with Coomassie Blue. 
  
 
  
 
 
 
 
 
 
Fig. 2.   Serines 86 and 90 are two major sites of Tip60 phosphorylation. A, amino acid 1‐211 region 
of Tip60 expressed and purified from insect cells was digested with trypsin, and the CIP‐treated and 
untreated  tryptic  fragments  were  analyzed  by  mass  spectrometry.  The  CIP  treatment  led  to  the 
complete displacement of a peak at 1483.30 kDa and the appearance of a new one at 1323.30. The 
loss of mass attributed to the CIP treatment (160 Da) shows the removal of two phosphate groups by 
CIP. The Q‐TOF sequencing of this peptide shows that it corresponds to the amino acid 81‐93 region 
of Tip60 containing only two phosphorylable residues, serine 86 and serine 90 (gray box). B, serines 
86 (S86) and 90 (S90) are sites of phosphorylation in mammalian cells. Site‐directed mutagenesis was 
used to replace Ser‐86, Ser‐90, or both by alanines. As a control, other irrelevant sites of Tip60 have 
been  also  mutated  to  alanines.  These  sites  are  glycine  380 (G380)  and  leucines  254 (L254)  and 
257. These proteins were expressed in HeLa cells, and their mobility was monitored after a Western 
blot and  immunodetection with an anti‐HA antibody. C, Tip60‐(1‐211) fragment containing the wild 
type sequence or mutated on Ser‐86 and Ser‐90  (Tip1‐211 S86/90) was also expressed  in HeLa cells, 
and the mobility of the CIP‐treated wild type peptide was compared with that of the Ser‐86/Ser‐90 
mutant. D,  purified HeLa  cell  nuclei were  isolated,  and  a  fraction was  incubated with  CIP  before 
extract preparation  (+). The extracts were  then analyzed by Western blotting using an anti  ‐Tip60 
antibody (14). 
   
 
 
 
  
 
Fig. 3.    Tip60 HAT activity  is controlled by phosphorylation. A, purified Tip60 expressed  in  insect 
cells was  treated with  increasing amounts of CIP  in  the absence  (lanes 2 and 3) or presence of CIP 
inhibitor NaF (lanes 4‐6). Lanes 1 and 4 show the activity of untreated Tip60. Treated and untreated 
Tip60 proteins were incubated with purified histone and [14C]acetyl‐CoA. The reaction was stopped, 
loaded on a 15% SDS‐PAGE, and analyzed by autoradiography. B, purified Tip60 was  left untreated 
(lane 7) or treated with CIP or heat‐inactivated CIP (lanes 8 and 9, respectively). The activity of wild 
type  Tip60 was  also  compared with  a protein harboring  a G  to A mutation  at position 380 (lanes 
10 and 11, respectively). C, the Ser‐86/Ser‐90 Tip60 mutant shows a reduced HAT activity. Wild type 
Tip60 or a mutated  version of  the protein harboring double  S  to A mutations at positions 86 and 
90 was produced in insect cells and purified, and their HAT activity was tested as noted above. After 
the  reaction, a  fraction was analyzed on a silver‐stained 8% SDS‐PAGE  to compare  the amounts of 
enzyme  used  (upper  panel).  The  middle  panel  (Autorad)  shows  the  labeling  of  histone  after  the 
reaction  by  wild  type  or  mutated  Tip60.  The  corresponding  Coomassie  Blue‐stained  gel  before 
autoradiography shows histones used in each reaction (lower panel).  
 
   
 
 
 
 
  
 
 
Fig. 4.   Tip60 Serine 90 is phosphorylated by cyclin B/Cdc2 in vitro. A, peptides corresponding to the 
Tip60 amino acids 82‐96  region, either wild  type  (wt) or containing  the  indicated mutations, were 
synthesized and used in a kinase reaction. B, the histogram shows that only the wild type peptide is a 
substrate for Cdc2 kinase.  
   
 
 
 
 
  
 
 
Fig. 5.   The arrest of cells at the G2/M phase of the cell cycle is associated with an enhancement of 
Tip60 phosphorylation. A, HeLa cells were treated with nocodazole (100 ng/ml) for 16 h and  lysed, 
and the migration of the endogenous Tip60 was monitored by Western blotting using an anti‐Tip60 
antibody. B, HeLa cells  stably expressing HA‐Tip60 were  treated with nocodazole  for 23 h, and 7 h 
before  harvest,  roscovitin  (50 µM) was  added where  indicated.  Cells were  lysed  and  analyzed  as 
above using an anti‐HA antibody. ‐, non‐treated cells. 
  
 
 
 
 
 
 
 
 
 
